Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.

Google DeepMind researchers have a new way to take toxic data and clean it for AI training. It could prove to be a powerful ...

In recent decades, sensor-less cars that rely on human decision-making have evolved into self-driving taxis that arrive on demand. Beate Mueller-Tiemann, PhD, CTO of the global CDMO Cytiva, points to ...